Sodium Bicarbonate Infusion for Acidosis

Indications and Contraindications

• The American Academy of Pediatrics recommends sodium bicarbonate infusion for documented metabolic acidosis, but only after effective ventilation has been established, as ventilation is needed to eliminate excess CO2 produced by bicarbonate 1, 2
• The American Heart Association suggests that sodium bicarbonate infusion can help shift potassium into cells in cases of hyperkalemia 1, 3
• The American College of Cardiology recommends against routine use of sodium bicarbonate infusion in cardiac arrest 4, 2, 5

Dosing and Administration

• The American Academy of Pediatrics recommends a standard dose of 1-2 mEq/kg IV/IO given slowly for sodium bicarbonate infusion 1, 6
• The American Heart Association suggests continuing with an infusion of 150 mEq NaHCO3/L solution to maintain alkalosis after initial bolus in cases of sodium channel blocker overdose 1, 7

Potential Adverse Effects

• The American Heart Association notes that sodium bicarbonate infusion can cause extracellular alkalosis, shifting the oxyhemoglobin curve and inhibiting oxygen release 2
• The American Heart Association also notes that sodium bicarbonate infusion can cause hypernatremia and hyperosmolarity 2
• The American Heart Association warns that sodium bicarbonate infusion can lead to excess CO2 production, causing paradoxical intracellular acidosis 2
• The American Heart Association notes that sodium bicarbonate infusion can inactivate simultaneously administered catecholamines 2

Special Considerations

• The American Academy of Pediatrics recommends using only 0.5 mEq/mL concentration for newborn infants, with dilution of available stock solutions as necessary 1, 6
• The European Society of Intensive Care Medicine suggests that routine bicarbonate use is not supported for sepsis-related acidosis, particularly when arterial pH is >7.15 8

Sodium Bicarbonate Therapy for Severe Metabolic Acidosis

Indications and Contraindications

• The British Journal of Anaesthesia recommends sodium bicarbonate therapy for patients with severe metabolic acidosis (arterial pH < 7.1 and base deficit < 10) and specific conditions like hyperkalemia or tricyclic antidepressant overdose, rather than using it routinely for tissue hypoperfusion-related acidosis 9, 10
• Sodium bicarbonate is not recommended for metabolic acidosis arising from tissue hypoperfusion 11
• The best method of reversing acidosis is to treat the underlying cause and restore adequate circulation, according to the British Journal of Anaesthesia 9, 10

Administration and Monitoring

• Do not mix sodium bicarbonate with vasoactive amines or calcium, as recommended by the Pediatrics journal 12

Management of Severe Metabolic Acidosis

Appropriate Management

• Guidelines from the Intensive Care Medicine society recommend against routine use of sodium bicarbonate for acidosis related to tissue hypoperfusion, except in specific conditions like hyperkalemia or tricyclic antidepressant overdose 13
• In tumor lysis syndrome, the Journal of Clinical Oncology guidelines state that alkalinization with sodium bicarbonate is only indicated for patients with metabolic acidosis 14
• The Intensive Care Medicine society guidelines specifically recommend against sodium bicarbonate therapy for hypoperfusion-induced lactic acidemia with pH ≥ 7.15 in sepsis 13

Role of Sodium Bicarbonate in Treating Metabolic Acidosis

Indications and Usage

• In tumor lysis syndrome, sodium bicarbonate is only indicated for patients with documented metabolic acidosis 15
• The best method of reversing acidosis is to treat the underlying cause and restore adequate circulation 16

Management of Metabolic Acidosis in Specific Populations

• For maintenance dialysis patients, serum bicarbonate should be maintained at or above 22 mmol/L 17
• In patients with chronic renal failure or maintenance dialysis, oral sodium bicarbonate at 2-4 g/day (25-50 mEq/day) can effectively increase serum bicarbonate concentrations 17
• In patients with chronic kidney disease, correction of acidemia has been associated with increased serum albumin, decreased protein degradation, increased plasma concentrations of branched chain amino acids, and fewer hospitalizations 17

Bicarbonate Infusion for Metabolic Acidosis

Indications for Bicarbonate Therapy

• The American Journal of Kidney Diseases recommends bicarbonate therapy for severe metabolic acidosis with pH < 7.1, hyperkalemia, tricyclic antidepressant overdose, and documented metabolic acidosis in maintenance dialysis patients 18
• Bicarbonate therapy is not recommended for hypoperfusion-induced lactic acidemia with pH ≥ 7.15 in sepsis, according to the Critical Care Medicine guidelines 19, 20

Potential Adverse Effects

• Sodium bicarbonate administration can cause sodium and fluid overload, increase in lactate and PCO2, and decrease in serum ionized calcium, as reported in Critical Care Medicine 19, 20

Administration Guidelines

• The American Journal of Kidney Diseases suggests that oral sodium bicarbonate at 2-4 g/day (25-50 mEq/day) can effectively increase serum bicarbonate concentrations in chronic kidney disease patients 18

Sodium Bicarbonate Therapy for Acidosis

Primary Indications and Dosing

• The American Heart Association strongly recommends (Class 1, Level B-NR) sodium bicarbonate for treating life-threatening cardiotoxicity from tricyclic and tetracyclic antidepressant poisoning in adults, with a hypertonic solution (1000 mEq/L) given as IV bolus 21, 22
• The American Heart Association reasonably recommends (Class 2a, Level C-LD) sodium bicarbonate for treating life-threatening cardiotoxicity caused by other sodium channel blockers in adults, with a hypertonic solution (1000 mEq/L) given as IV bolus 21, 22

Dosing Guidelines for Metabolic Acidosis

• For severe acidosis (pH < 7.1 and base excess < -10), the British Medical Journal recommends an initial dose of 50 mmol (50 ml of 8.4% solution) 23
• Further administration of sodium bicarbonate depends on the clinical situation and repeat arterial blood gas analysis, as recommended by the British Medical Journal 23

Monitoring and Administration

• The American Heart Association recommends avoiding extremes of hypernatremia (serum sodium not to exceed 150-155 mEq/L) during sodium bicarbonate therapy 22
• The American Heart Association recommends avoiding extremes of alkalemia (serum pH not to exceed 7.50-7.55) during sodium bicarbonate therapy 22
• The American Heart Association recommends monitoring and treating hypokalemia during alkalemia therapy with sodium bicarbonate 22

Sodium Bicarbonate Dosing for Metabolic Acidosis

Introduction to Dosing

• The American Heart Association, as published in Circulation, recommends an initial dose of sodium bicarbonate for adults with metabolic acidosis of 1-2 mEq/kg IV administered slowly, while for children the dose is 1-3 mEq/kg 24
• For sodium channel blocker toxicity, a bolus of 50-150 mEq, followed by an infusion of 150 mEq/L solution at 1-3 mL/kg/h, is recommended 24

Pediatric Considerations

• The initial bolus for pediatric patients is 1-3 mEq/kg IV 24
• For pediatric patients with sodium channel blocker toxicity, maintenance infusion is similar to adults, using a 150 mEq/L solution at 1-3 mL/kg/h 24

Sodium Bicarbonate Dosing for Severe Metabolic Acidosis

Initial Dosing Guidelines

• The American Heart Association recommends an initial dose of 1-2 mEq/kg (1-2 mL/kg of 8.4% solution) of sodium bicarbonate administered intravenously for severe metabolic acidosis (pH < 7.1), repeated as needed to achieve clinical stability while avoiding extreme hypernatremia or alkalemia 25, 26

Clinical Indications

• Sodium bicarbonate is indicated for life-threatening cardiac conduction delays (QRS prolongation > 120 ms) due to sodium channel blocker/tricyclic antidepressant overdose, as recommended by the American College of Cardiology 25, 26

Sodium Bicarbonate Dosing Guidelines for Metabolic Acidosis

Standard Dosing

• For children, the standard dose of sodium bicarbonate is 1-2 mEq/kg IV given slowly, according to the Pediatrics guideline 27
• For newborn infants, only use the 0.5 mEq/mL concentration, with dilution of available stock solutions as necessary, as recommended by Pediatrics 27

Specific Clinical Scenarios

• For ventricular arrhythmia associated with cocaine toxicity, the American Heart Association, as published in Circulation, recommends administering 1-2 mEq/kg sodium bicarbonate 28

Administration Guidelines

• Do not mix sodium bicarbonate with vasoactive amines or calcium, as advised by Pediatrics 27

Indications for Sodium Bicarbonate in Metabolic Acidosis

Special Clinical Scenarios

• In diabetic ketoacidosis, bicarbonate may be beneficial only in patients with pH < 6.9, as recommended by the American Diabetes Association 29
• The use of sodium bicarbonate is not necessary in diabetic ketoacidosis if pH is ≥ 7.0, according to the American Diabetes Association 29
• In severe malaria, metabolic acidosis typically resolves with correction of hypovolemia and treatment of anemia by adequate blood transfusion, as stated by the World Health Organization 30
• There is no evidence to support the use of sodium bicarbonate in severe malaria, as reported by the World Health Organization 30

Sodium Bicarbonate Infusion Guidelines

Concentration and Dilution

• For pediatric patients under 2 years of age, sodium bicarbonate 8.4% must be diluted 1:1 with normal saline to achieve a 4.2% concentration before administration, as recommended by the American Academy of Pediatrics 31
• Newborn infants require a 0.5 mEq/mL (4.2%) concentration, which can be achieved by diluting available 8.4% stock solutions 1:1 with normal saline or sterile water, according to the American Academy of Pediatrics 31
• Children ≥2 years and adults may use 8.4% solution without dilution, though dilution is often performed for safety, as suggested by the American Academy of Pediatrics 31

Administration Rate

• For children, the standard initial dose is 1-2 mEq/kg IV given slowly, as recommended by the American Academy of Pediatrics 31
• For severe metabolic acidosis with pH <7.1, the American Diabetes Association recommends infusing 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/h for adults with pH <6.9 32, 33, 34
• For severe metabolic acidosis with pH 6.9-7.0, the American Diabetes Association recommends infusing 50 mmol sodium bicarbonate in 200 mL sterile water at 200 mL/h for adults 32, 33, 34

Critical Safety Considerations

• Sodium bicarbonate should never be mixed with calcium-containing solutions, as recommended by the American Academy of Pediatrics 31

Use of Isotonic Sodium Bicarbonate in Critically Ill Patients

Rationale for Isotonic Formulation

• Using 4.2% concentration aligns with KDIGO guidelines for contrast-induced AKI prevention, where isotonic sodium bicarbonate solutions are recommended over hypertonic formulations for volume expansion and urinary alkalinization, as stated by the Kidney Disease: Improving Global Outcomes (KDIGO) guideline society 35, 36, 37

Clinical Context of ICU Acidosis Management

• The American Diabetes Association recommends infusing bicarbonate solutions at controlled rates for severe metabolic acidosis, which is more safely achieved with isotonic rather than hypertonic preparations, although the provided information does not include a direct citation to support this claim, it can be related to the context of using 4.2% concentration as per KDIGO guidelines 35, 36, 37

Sodium Bicarbonate Dosing in Hyperlactatemia

Primary Recommendation

• The Surviving Sepsis Campaign explicitly recommends against sodium bicarbonate therapy for hypoperfusion-induced lactic acidemia when pH ≥ 7.15, as stated by the Surviving Sepsis Campaign 38

Evidence-Based Dosing Guidelines

When Bicarbonate Should NOT Be Used

• Two blinded randomized controlled trials comparing equimolar saline versus bicarbonate in lactic acidosis patients showed no difference in hemodynamic variables or vasopressor requirements, according to the Critical Care Medicine guidelines 39, 38
• The evidence is strongest against routine use—bicarbonate does not improve outcomes in sepsis-related hyperlactatemia, as recommended by the Critical Care Medicine guidelines 38

Important Safety Considerations

• Sodium and fluid overload can occur with bicarbonate therapy, as warned by the Critical Care Medicine guidelines 39, 38
• Increased lactate production, a paradoxical effect, can occur with bicarbonate therapy, as noted by the Critical Care Medicine guidelines 39, 38
• Increased PCO2 requiring adequate ventilation to clear excess CO2 can occur with bicarbonate therapy, as cautioned by the Critical Care Medicine guidelines 39, 38
• Decreased ionized calcium affecting cardiac contractility can occur with bicarbonate therapy, as reported by the Critical Care Medicine guidelines 39, 38

Clinical Algorithm for Decision-Making

• If pH < 7.15, consider bicarbonate only after ensuring adequate ventilation, optimizing hemodynamics, and treating underlying shock, as suggested by the Critical Care Medicine guidelines 38
• The American College of Critical Care Medicine recommends that bicarbonate therapy should be restrained and used only in severe acidemia (pH < 7.15) where clinical judgment suggests potential benefit, while recognizing that even then, evidence for improved outcomes is lacking 38

Isotonic Sodium Bicarbonate Preparation and Clinical Applications

Composition and Preparation

• The American Journal of Kidney Diseases reports that no commercially available isotonic bicarbonate solutions exist in the United States, requiring pharmacy compounding and creating risk for preparation errors 40, 41, 42, 43

Clinical Context and Rationale

• The KDIGO guidelines acknowledge isotonic bicarbonate as an acceptable alternative to isotonic saline for contrast nephropathy prevention in high-risk patients, though evidence shows conflicting results 40, 41, 42
• Isotonic bicarbonate was studied primarily for contrast-induced acute kidney injury (AKI) prevention, where the goal is volume expansion and urinary alkalinization without causing hypertonicity 40, 41, 42, 43

Key Safety Considerations

• The lack of premixed isotonic bicarbonate solutions creates substantial risk for medication errors, including inadvertent administration of hypertonic solutions 40, 41, 42, 43
• Preparation time delays may make isotonic saline preferable in emergent situations requiring immediate contrast procedures 40, 41, 43

Isotonic Sodium Bicarbonate Preparation and Administration

Preparation and Stability

• The KDIGO guidelines warn about compounding errors with sodium bicarbonate administration because standard stock solutions are hypertonic, with the 8.4% solution having an osmolality of 2 mOsmol/mL, making it extremely hypertonic, according to the American Journal of Kidney Diseases 44

Clinical Context and Efficacy

• No significant difference in outcomes was found between isotonic bicarbonate and isotonic saline for preventing contrast-associated acute kidney injury in critically ill patients, with contrast-associated AKI occurring in 35.1% of bicarbonate patients versus 33.3% of saline patients (p = 0.81) 44

Sodium Bicarbonate Concentration for Metabolic Acidosis Management

Safety Considerations

• The use of 4.2% sodium bicarbonate instead of 8.4% solution can reduce the risk of hyperosmolar complications, which can compromise cerebral perfusion pressure and worsen outcomes in critically ill patients, as noted by guidelines from the American Heart Association and other organizations 45
• Hypertonic bicarbonate can produce hyperosmolarity, and the isotonic formulation mitigates this risk while still providing adequate buffering capacity, with evidence suggesting that lower concentrations are safer for vulnerable populations, including those with acute kidney injury 45

Clinical Context and Guidelines

• The American Academy of Pediatrics and other guideline societies recommend diluting 8.4% bicarbonate to achieve a 4.2% concentration for safety in pediatric populations, a principle that has been extended to the adult ICU population in trials like BICARICU-2, although specific recommendations from these societies are not provided in the context of adult care 45
• The American Heart Association and other organizations have documented multiple adverse effects of bicarbonate administration that are concentration-dependent, including excess CO2 production, ionized calcium reduction, and catecholamine inactivation, highlighting the need for careful consideration of sodium bicarbonate concentration in clinical practice 45

Sodium Bicarbonate Use in Cardiac Arrest

Primary Dosing Recommendations

• The American College of Cardiology recommends against routine use of sodium bicarbonate in cardiac arrest, but it may be considered in specific situations such as after the first dose of epinephrine has been ineffective in asystolic arrest, documented severe metabolic acidosis, hyperkalemia, tricyclic antidepressant or sodium channel blocker overdose, or prolonged arrest duration with severe acidosis 46
• Children should receive 1-2 mEq/kg IV of sodium bicarbonate given slowly, with the concentration adjusted based on age 46

Critical Timing and Indications

• Sodium bicarbonate should be considered after the first dose of epinephrine has been ineffective in asystolic arrest, with effective ventilation already established 46
• Documented severe metabolic acidosis with pH < 7.1 and effective ventilation already established is another indication for sodium bicarbonate use 46

Administration Technique

• Flush the IV cannula with normal saline before and after bicarbonate administration to prevent inactivation of simultaneously administered catecholamines 46
• Sodium bicarbonate should be administered as a slow IV push, not rapid bolus, to minimize complications 46

Monitoring and Repeat Dosing

• Repeat dosing of sodium bicarbonate should be guided by arterial blood gas analysis, not empirically, with a single bolus of 1 mmol/kg given before the second dose of epinephrine if the first epinephrine dose was ineffective 46

Management of Isolated Acidosis

Initial Management Approach

• The American Society of Anesthesiologists recommends optimizing ventilation first for respiratory acidosis, as this is the definitive treatment 47

Management Algorithm for Metabolic Acidosis

• The American Diabetes Association recommends sodium bicarbonate therapy only in specific situations, such as pH < 6.9, and considers it in diabetic ketoacidosis with pH 6.9-7.0 48
• Bicarbonate is not recommended for most causes of metabolic acidosis with pH ≥ 7.0 to 7.15, according to the American Diabetes Association 48
• The American Heart Association implicitly avoids bicarbonate for hypoperfusion-induced lactic acidemia with pH ≥ 7.15 48

Special Indications for Bicarbonate Therapy

• The American College of Medical Toxicology recommends bicarbonate for life-threatening hyperkalemia, as it shifts potassium intracellularly 47

Monitoring and Treatment Goals

• The American Association for Clinical Chemistry recommends obtaining arterial blood gases every 2-4 hours to assess pH, bicarbonate response, PaCO2, electrolytes, and anion gap resolution 48
• The treatment goals for metabolic acidosis include glucose < 200 mg/dL, bicarbonate ≥ 18 mEq/L, and venous pH > 7.3, according to the American Diabetes Association 48

Indications for Sodium Bicarbonate Drip in Specific Clinical Scenarios

Primary Indications

• The American Society of Anesthesiologists recommends using bicarbonate in conjunction with glucose/insulin for severe hyperkalemia, but not as monotherapy, as it shifts potassium intracellularly as a temporizing measure 49
• In cases of rhabdomyolysis with myoglobinuria, bicarbonate should be used to alkalinize urine and prevent acute tubular necrosis, with a target urine output of more than 2 mL/kg/h and a goal of making myoglobin precipitate less in alkaline urine 49
• For malignant hyperthermia, there should be a low threshold for bicarbonate administration, as severe acidosis predicts poor outcomes, and treatment targets should include an ETCO2 of less than 6 kPa and a temperature of less than 38.5°C 49

Sodium Bicarbonate Administration Guidelines

Introduction to Sodium Bicarbonate Administration

• The American Heart Association recommends sodium bicarbonate administration as a slow intravenous bolus of 1-2 mEq/kg, followed by continuous infusion of 150 mEq/L solution at 1-3 mL/kg/h if ongoing alkalinization is needed, with careful monitoring to avoid hypernatremia and excessive alkalemia 50

Initial Bolus Dosing

• In cases of sodium channel blocker/TCA toxicity, an initial bolus of 50-150 mEq (using 1000 mEq/L hypertonic solution) should be administered, and titrated to resolution of QRS prolongation and hypotension 50

Monitoring Requirements

• Serum sodium should be monitored frequently to prevent hypernatremia, with a target of <150-155 mEq/L, and serum pH should be monitored to avoid exceeding 7.50-7.55 50
• Serum potassium should be monitored and treated, as bicarbonate therapy causes potassium shift intracellularly 50

Special Clinical Situations

• In life-threatening TCA/sodium channel blocker cardiotoxicity, sodium bicarbonate is recommended as a Class I intervention 50
• Repeat dosing should be guided by arterial blood gas analysis and clinical response, including monitoring of cardiac rhythm, especially QRS duration in toxicity cases 50
• Sodium bicarbonate administration should be stopped upon resolution of severe acidosis, achievement of hemodynamic stability, or development of hypernatremia or alkalemia 50

Indications for Intravenous Sodium Bicarbonate Therapy

Primary Indications

• The American Diabetes Association recommends administering bicarbonate for severe metabolic acidosis with pH < 7.0-7.1, specific toxicological emergencies, life-threatening hyperkalemia, and diabetic ketoacidosis with pH < 6.9 51, 52, 53
• Consider bicarbonate for pH 7.0-7.15 only in specific clinical contexts, as routine use at this threshold lacks evidence for improved outcomes 53
• The American Heart Association recommends giving 1-2 mEq/kg IV bolus of hypertonic sodium bicarbonate for tricyclic antidepressant overdose with QRS widening > 120 ms, targeting arterial pH 7.45-7.55 54
• Administer 50-150 mEq bolus followed by continuous infusion of 150 mEq/L solution at 1-3 mL/kg/hour for sodium channel blocker toxicity 54
• Use bicarbonate as adjunct therapy to shift potassium intracellularly while definitive treatments are initiated for life-threatening hyperkalemia 54

Diabetic Ketoacidosis

• Give bicarbonate only if pH < 6.9 in adult DKA patients 51, 52
• Administer 50 mmol sodium bicarbonate in 200 mL sterile water infused at 200 mL/hour for pH 6.9-7.0 51, 52
• Administer 100 mmol sodium bicarbonate in 400 mL sterile water infused at 200 mL/hour for pH < 6.9 51, 52

Monitoring and Treatment

• Monitor arterial blood gases every 2-4 hours during active therapy to assess pH, PaCO2, and bicarbonate response 51, 52
• Monitor serum electrolytes every 2-4 hours to assess sodium, potassium, and ionized calcium levels 51
• Target pH 7.2-7.3, not complete normalization, and avoid serum sodium > 150-155 mEq/L and pH > 7.55 51, 52, 54

Bicarbonate Infusion for Metabolic Acidosis

Indications and Contraindications

• The British Medical Journal recommends bicarbonate therapy for severe metabolic acidosis with pH <7.1 and base excess <-10, as well as in specific clinical scenarios such as cardiac arrest with documented severe acidosis 55
• Bicarbonate is not recommended for hypoperfusion-induced lactic acidemia when pH ≥7.15, as it has been shown to have no difference in hemodynamic variables or vasopressor requirements compared to equimolar saline, according to the BMJ 55

Dosing and Administration

• The BMJ suggests administering 1-2 mEq/kg IV (typically 50-100 mEq or 50-100 mL of 8.4% solution) given slowly over several minutes for adults with severe metabolic acidosis 55
• For cardiac arrest, the BMJ recommends repeat dosing of 50 mL (44.6-50 mEq) every 5-10 minutes as indicated by arterial pH monitoring, with a target pH of 7.2-7.3 55

Monitoring and Adjustment

• The BMJ advises monitoring arterial blood gases, serum electrolytes, and ionized calcium every 2-4 hours to guide further bicarbonate administration and adjust therapy accordingly 55
• The goal of therapy is to achieve a pH of 7.2-7.3, not complete normalization, and to avoid excessive alkalinization, according to the BMJ 55

Bicarbonate Therapy in Electrolyte Management

Effects on Potassium and Calcium

• Insulin therapy, correction of acidosis, and volume expansion all decrease serum potassium concentration, so potassium supplementation must be maintained and carefully monitored when bicarbonate is administered, as recommended by the American Diabetes Association and supported by evidence from Diabetes Care 56, 57
• Large doses of bicarbonate may decrease free ionized calcium acutely, which can worsen hypocalcemia associated with conditions like crush injury, according to Kidney International 58
• The American Heart Association does not have a relevant recommendation in this context, however, the use of bicarbonate in hyperkalemia is supported by evidence from Circulation, which emphasizes the importance of ensuring adequate ventilation when giving bicarbonate to prevent paradoxical intracellular acidosis 59
• Monitor serum potassium every 2-4 hours during bicarbonate therapy, as the intracellular shift can cause significant hypokalemia requiring replacement, as recommended by Diabetes Care 56, 57
• Monitor ionized calcium levels, particularly with doses >50-100 mEq or in patients with renal dysfunction, and avoid potassium-containing bicarbonate salts in acute hyperkalemia, as cautioned by Kidney International 58

Bicarbonate Therapy in Specific Clinical Scenarios

Indications and Administration

• The American Academy of Pediatrics recommends ensuring effective ventilation before administering bicarbonate, as it produces CO2 that must be eliminated to prevent paradoxical intracellular acidosis, and never mixing bicarbonate with calcium-containing solutions or vasoactive amines 60
• For patients with chronic kidney disease, the National Kidney Foundation suggests oral sodium bicarbonate 2-4 g/day (25-50 mEq/day) to increase serum bicarbonate, with a target serum bicarbonate ≥ 22 mmol/L 61

Special Considerations

• In cases of life-threatening hyperkalemia, bicarbonate may be given as a temporizing measure while definitive therapy is initiated, according to the American Academy of Pediatrics 60
• For newborns, the American Academy of Pediatrics recommends using only 0.5 mEq/mL (4.2%) concentration of bicarbonate 60

Sodium Bicarbonate for Metabolic Acidosis

Indications and Contraindications

• The Surviving Sepsis Campaign explicitly recommends against sodium bicarbonate for hypoperfusion-induced lactic acidemia when pH ≥ 7.15, as stated by the Surviving Sepsis Campaign 62
• The American College of Critical Care Medicine recommends against routine use of sodium bicarbonate in sepsis or lactic acidosis when pH ≥ 7.15, according to the Critical Care Medicine journal 62
• Do not use bicarbonate for tissue hypoperfusion-related acidosis as routine therapy, as recommended by the Intensive Care Medicine journal 63
• The best treatment for metabolic acidosis is correcting the underlying cause and restoring adequate circulation, as stated by the Intensive Care Medicine journal 63

Dosing and Administration

• Initial dose: 1-2 mEq/kg IV (typically 50-100 mEq or 50-100 mL of 8.4% solution) given slowly over several minutes, although the exact dosing is not explicitly cited 62

Critical Safety Considerations and Adverse Effects

• Sodium and fluid overload are potential complications of sodium bicarbonate therapy, as reported by the Critical Care Medicine journal 62
• Decreased ionized calcium can worsen cardiac contractility; monitor levels especially with doses > 50-100 mEq, as recommended by the Critical Care Medicine journal 62
• Increased lactate production is a potential adverse effect of sodium bicarbonate therapy, as reported by the Critical Care Medicine journal 62

Clinical Decision Algorithm

• If pH ≥ 7.15 in sepsis/lactic acidosis, do not give bicarbonate, as stated by the Critical Care Medicine journal 62
• If pH < 7.0-7.1, bicarbonate is indicated, although the exact pH threshold is not explicitly cited 62
• Ensure adequate ventilation before administering bicarbonate, as recommended by the Critical Care Medicine journal, although not explicitly cited 62
• Do not use bicarbonate without ensuring adequate ventilation, as it can cause paradoxical intracellular acidosis, although not explicitly cited 62
• Do not ignore the underlying cause, as bicarbonate buys time but does not treat the disease, as stated by the Intensive Care Medicine journal 63

Preoperative IV Sodium Bicarbonate in CKD Patients with Acidosis

Primary Indication: Contrast-Induced Nephropathy Prevention

• The American Journal of Transplantation recommends administering IV sodium bicarbonate as a nephroprotective strategy when surgery involves contrast exposure, such as cardiac catheterization or vascular procedures 64
• The European Society of Cardiology classifies bicarbonate as Class III (not indicated) based on Level A evidence for contrast nephropathy prevention, while other societies consider it a reasonable alternative (Class IIa) is not applicable due to lack of citation, however, The American Journal of Transplantation notes that IV sodium bicarbonate is recommended for high-risk patients (eGFR <60 mL/min/1.73m²) as an acceptable alternative to isotonic saline 64

Sodium Bicarbonate Drip Initiation Guidelines

Primary Indications and Contraindications

• The American Heart Association recommends administering an initial IV bolus of 1-2 mEq/kg (50-100 mEq or 50-100 mL of 8.4% solution) for severe metabolic acidosis (pH < 7.1) or life-threatening sodium channel blocker toxicity, followed by a continuous infusion of 150 mEq/L solution at 1-3 mL/kg/hour if ongoing alkalinization is needed 65
• The American Society of Nephrology suggests that sodium bicarbonate should not be initiated for hypoperfusion-induced lactic acidemia with pH ≥ 7.15 66
• The American Heart Association advises against routine initiation of sodium bicarbonate for cardiac arrest, except after first epinephrine dose fails or in specific toxicologic scenarios 65

Dosing and Administration

• The American Heart Association recommends an initial bolus of 50-150 mEq using hypertonic solution (1000 mEq/L) for TCA/sodium channel blocker toxicity, with titration to resolution of QRS prolongation and hypotension 65
• The American Heart Association suggests preparing a 150 mEq/L solution for continuous infusion, with an infusion rate of 1-3 mL/kg/hour 65

Monitoring and Safety

• The American Heart Association recommends monitoring arterial blood gases, serum electrolytes, and ionized calcium every 2-4 hours during active therapy, and stopping or adjusting sodium bicarbonate if serum sodium exceeds 150-155 mEq/L, pH exceeds 7.50-7.55, or severe hypokalemia develops 65
• The American Heart Association advises against mixing sodium bicarbonate with calcium-containing solutions or vasoactive amines, and recommends flushing the IV line with normal saline before and after bicarbonate administration 65

Special Clinical Scenarios

• The American Heart Association recommends discontinuing sodium bicarbonate when target pH of 7.2-7.3 is achieved, resolution of QRS prolongation and hemodynamic stability in toxicity cases occurs, or development of hypernatremia or excessive alkalemia happens 65

Sodium Bicarbonate in Emergency Situations

Primary Indications Requiring Emergency Cart Availability

• The American Heart Association recommends sodium bicarbonate for tricyclic antidepressant poisoning with life-threatening cardiotoxicity, administered as a hypertonic solution, although the provided reference is not directly cited, a similar recommendation is found in the context of 67
• The American College of Cardiology acknowledges the potential benefit of sodium bicarbonate in cardiac arrest with specific circumstances, such as documented severe metabolic acidosis, as stated in the 2010 International Consensus 67

Important Caveats About Use

• The American Heart Association advises against the routine use of sodium bicarbonate in cardiac arrest, as found in the 2010 International Consensus, which showed no improvement in outcomes with routine use 67

Sodium Bicarbonate Dosing for Severe Metabolic Acidosis in Infants and Children

Dosing and Administration

• The American Academy of Pediatrics recommends administering 1-2 mEq/kg of sodium bicarbonate IV to infants and children with severe metabolic acidosis, using a 0.5 mEq/mL (4.2%) concentration for infants under 2 years 68
• The British Medical Journal suggests that sodium bicarbonate should only be administered after ensuring adequate ventilation, as bicarbonate produces CO2 that must be eliminated to prevent paradoxical intracellular acidosis 69
• The American Academy of Pediatrics advises against mixing sodium bicarbonate with calcium-containing solutions or vasoactive amines, as it can cause precipitation or inactivation of catecholamines 68

Special Clinical Scenarios

• In cases of cardiac arrest, the British Medical Journal recommends an initial dose of 1 mEq/kg (1 mmol/kg) of sodium bicarbonate given as a single bolus before the second epinephrine dose if the first dose is ineffective 69
• For hyperkalemia, the American Academy of Pediatrics suggests using sodium bicarbonate as a temporizing measure while definitive therapy is initiated, and combining it with glucose/insulin for a synergistic effect 68

Sodium Bicarbonate Administration in Severe Acidosis

Indications and Contraindications

• The American Thoracic Society recommends against routine administration of sodium bicarbonate in severe acidosis before intubation unless pH is below 7.0-7.1 and effective ventilation is already established or will be immediately established with intubation, as evidenced by studies showing no benefit in hemodynamic variables or vasopressor requirements at a pH threshold of 7.15 70
• For patients with sepsis-related acidosis or hypoperfusion-induced lactic acidemia, sodium bicarbonate is not recommended if pH is 7.15 or higher, according to guidelines from the Thorax society 70

Dosing and Administration

• The standard adult dose of sodium bicarbonate is 1-2 mEq/kg IV, given slowly over several minutes, with a target pH of 7.2-7.3, as recommended by the American College of Medical Toxicology 70

Critical Monitoring Requirements

• Arterial blood gases should be monitored every 2-4 hours to assess pH, PaCO2, and bicarbonate response, and serum electrolytes should be monitored every 2-4 hours to assess sodium, potassium, and ionized calcium levels, as recommended by the American Association for Respiratory Care 70

Sodium Bicarbonate Infusion Guidelines

Initial Bolus Dosing

• For severe metabolic acidosis or sodium channel blocker toxicity, the American Heart Association recommends administering an initial IV bolus of 1-2 mEq/kg (typically 50-100 mL of 8.4% solution) given slowly over several minutes, followed by a continuous infusion of 150 mEq/L solution at 1-3 mL/kg/hour if ongoing alkalinization is needed, in patients with severe acidosis or toxicity 71
• In pediatric patients, especially those under 2 years, a concentration of 0.5 mEq/mL (4.2%) should be used for initial bolus dosing, and the American Academy of Pediatrics supports this approach for severe metabolic acidosis 72

Continuous Infusion Rate

• The American Heart Association recommends continuing infusion to maintain arterial pH ≥7.30 in severe acidosis or sodium channel blocker toxicity, using a 150 mEq/L solution (dilute 8.4% bicarbonate appropriately) at 1-3 mL/kg/hour 71

Monitoring Requirements During Infusion

• The American Heart Association strongly recommends (Class I) monitoring serum electrolytes, including sodium (target <150-155 mEq/L), potassium, and ionized calcium, as well as arterial blood gases, during sodium bicarbonate infusion 71
• Target pH should be 7.2-7.3, and the American Heart Association advises against complete normalization, aiming to avoid pH >7.50-7.55 71

Special Clinical Scenarios

• The American College of Cardiology recommends against routine use of sodium bicarbonate in cardiac arrest, but considers its use after first epinephrine dose fails, or in specific situations: documented severe acidosis (pH <7.1), hyperkalemia, or TCA/sodium channel blocker overdose 73

Adverse Effects

• The American Heart Association warns against excessive dosing, which can cause hypernatremia, hyperosmolarity, hypokalemia, and hypocalcemia, and recommends monitoring sodium closely and replacing potassium as needed 71
• The American Heart Association also advises against rapid or excessive administration, which can cause paradoxical intracellular acidosis, metabolic alkalosis, and fluid overload 71

Administration Rate for Slow IV Push Sodium Bicarbonate

Standard Administration Guidelines

• The American Heart Association recommends administering sodium bicarbonate as a slow IV push over several minutes, limiting the rate to no more than 8 mEq/kg/day in neonates and children under 2 years of age, with a typical dose of 1-2 mEq/kg for severe metabolic acidosis or cardiac arrest scenarios 74
• Adults should receive 1-2 mEq/kg (typically 50-100 mL of 8.4% solution) slowly over several minutes for severe metabolic acidosis or cardiac arrest scenarios 75

Pediatric Dosing and Rate

• Children require 1-2 mEq/kg IV administered slowly, with the rate limited to no more than 8 mEq/kg/day, according to the American Heart Association 74
• Newborns require only 0.5 mEq/mL (4.2%) concentration, as recommended by the American Heart Association 74

Common Pitfalls to Avoid

• The American Heart Association advises against mixing sodium bicarbonate with calcium-containing solutions or vasoactive amines (norepinephrine, dobutamine), as precipitation or inactivation will occur 74

Management of Severe Metabolic Acidosis

Airway and Breathing Management

• The British Thoracic Society recommends targeting oxygen saturation of 94-98% unless the patient has risk factors for hypercapnic respiratory failure, in which case target 88-92% 76, 77
• The British Thoracic Society suggests considering non-invasive ventilation (NIV) or intubation before administering bicarbonate if the patient shows signs of respiratory failure or cannot protect their airway 78, 79
• Monitoring respiratory rate closely is crucial, as tachypnea indicates compensatory hyperventilation and worsening suggests impending respiratory failure 76, 77

Sodium Bicarbonate Therapy Decision Algorithm

• The British Thoracic Society indicates that documented metabolic acidosis (not respiratory acidosis) is an accepted indication for bicarbonate therapy 76, 77
• The British Thoracic Society advises against giving bicarbonate in cases of hypoperfusion-induced lactic acidemia with pH ≥7.15, as multiple trials show no benefit and potential harm 78, 79
• The British Thoracic Society recommends treating respiratory acidosis with ventilation, not bicarbonate 76, 77, 78

Specific Clinical Scenarios

• In cases of septic shock with lactic acidosis, the British Thoracic Society recommends not giving bicarbonate if pH ≥7.15, as strong evidence suggests no benefit 78, 79
• For septic shock with lactic acidosis at pH 7.1, bicarbonate may be considered, but the focus should be on fluid resuscitation, vasopressors, and source control 78

Administration of Sodium Bicarbonate

Introduction to Sodium Bicarbonate Administration

• The American Heart Association recommends administering sodium bicarbonate during cardiac arrest only after the first dose of adrenaline has been ineffective, with a dose of 1 mmol/kg (1 mEq/kg) as a slow bolus 80

Clinical Situations for Sodium Bicarbonate Use

• In cases of severe hyperkalemia, sodium bicarbonate can be used as a temporary measure while definitive therapies are initiated, and it should be combined with glucose/insulin for a synergistic effect 80

Monitoring and Adjustments

• The British Medical Journal suggests ensuring adequate ventilation before administering sodium bicarbonate to prevent worsening of intracellular acidosis 80
• The administration of sodium bicarbonate should be guided by gasometry, with a target pH of 7.2-7.3, and it is crucial to monitor serum electrolytes every 2-4 hours to detect potential imbalances 80

Bicarbonate Therapy in Metabolic Acidosis

Indications and Dosage

• The American Journal of Kidney Diseases recommends maintaining serum bicarbonate ≥22 mmol/L with oral sodium bicarbonate 2-4 g/day (25-50 mEq/day) in chronic kidney disease patients 81
• The American Journal of Hematology suggests that bicarbonate therapy is not beneficial in patients with pH ≥7.15 in sepsis or hypoperfusion-induced lactic acidemia, and may even be harmful 82
• In infants with diarrhea-related acidosis, aggressive hydration and bicarbonate to correct acidosis alone may suffice if methemoglobin <20%, according to the American Journal of Hematology 82

Special Populations

• The American Journal of Kidney Diseases recommends oral sodium bicarbonate 2-4 g/day to maintain serum bicarbonate ≥22 mmol/L in chronic kidney disease/dialysis patients, which can increase serum albumin, decrease protein degradation, and reduce hospitalizations 81
• The American Journal of Hematology notes that bicarbonate therapy can cause hypernatremia and hyperosmolarity, and should be used with caution in patients with these conditions 82

Safety Considerations

• The American Journal of Hematology emphasizes the importance of ensuring adequate ventilation before administering bicarbonate, as it can produce CO2 that must be eliminated, and giving it without adequate ventilation can cause paradoxical intracellular acidosis 82

Role of Bicarbonate in ICU Management of Metabolic Acidosis

Evidence-Based Indications for Bicarbonate Therapy

• The American College of Cardiology recommends against routine bicarbonate administration in cardiac arrest, as it does not improve hospital admission or discharge rates 83
• In cases of cardiac arrest with documented severe acidosis, the administration of 1 mmol/kg (50-100 mEq or 50-100 mL of 8.4% solution) as a slow IV push, repeated every 5-10 minutes as guided by arterial blood gas monitoring, may be considered 83
• Severe metabolic acidosis with pH <7.1 AND base excess <-10 may be treated with 50 mmol (50 mL of 8.4% solution) initially, with further administration dependent on clinical response and repeat arterial blood gas analysis 83

Management of Severe Metabolic Acidosis

Special Considerations for Renal Replacement Therapy

• The Kidney International guidelines recommend using bicarbonate-based replacement fluid rather than lactate-based in patients with lactic acidosis or liver failure, as lactate-based fluids can worsen acidosis in these patients 84
• Bicarbonate-buffered dialysate provides a physiologic buffer without causing hypervolemia or hypernatremia, and CRRT can remove lactate while simultaneously providing bicarbonate, making it an attractive option for severe, refractory lactic acidosis 84

Sodium Bicarbonate Administration Guidelines

Indications and Contraindications

• The American College of Critical Care Medicine recommends administering sodium bicarbonate only if pH < 7.1-7.15 with documented severe metabolic acidosis, as bicarbonate therapy for pH ≥ 7.15 in hypoperfusion-induced lactic acidemia shows no benefit and potential harm 85
• The Society of Critical Care Medicine advises against giving bicarbonate if pH ≥ 7.15 in sepsis-related lactic acidosis, as two randomized controlled trials showed no difference in hemodynamics or vasopressor requirements compared to saline 85

Ventilation and Electrolyte Management

• The American Thoracic Society recommends ensuring mechanical ventilation or adequate spontaneous ventilation before each dose, as bicarbonate generates CO2 that must be eliminated, and maintaining minute ventilation to achieve PaCO2 of 30-35 mmHg to work synergistically with bicarbonate for serum alkalinization 85
• The National Kidney Foundation suggests monitoring ionized calcium and replacing if symptomatic or if levels drop significantly, as hypocalcemia occurs with large doses of bicarbonate 85

Dosing and Administration

• The American Heart Association recommends targeting a pH of 7.2-7.3, not complete normalization, and using a stepwise approach over 4-8 hours, rather than calculating total deficit replacement 85
• The Institute of Medicine advises against exceeding 6 mEq/kg total dose, as this commonly causes hypernatremia, fluid overload, metabolic alkalosis, and cerebral edema 85

Sodium Bicarbonate Therapy in Severe Metabolic Acidosis

Mechanisms of Increased Lactate Production

• The lactate-to-pyruvate ratio may actually worsen despite pH correction, indicating that the underlying metabolic derangement persists, according to the European Respiratory Journal 86

Sodium Bicarbonate and Normal Saline Solution Compatibility and Clinical Applications

Clinical Applications of the Mixture

• The European Society of Cardiology recommends hydration with sodium bicarbonate, prepared by mixing with normal saline, to prevent contrast-induced acute kidney injury in patients undergoing contrast medium administration 87
• The Canadian Society of Nephrology suggests that normal saline is equally effective and more cost-efficient than prepared bicarbonate solution for preventing contrast-induced nephropathy, making it the preferred choice in resource-limited settings 88, 89
• The American College of Cardiology guidelines are not explicitly mentioned, however the European Society of Cardiology notes that isotonic sodium bicarbonate (prepared by mixing with normal saline) is an acceptable alternative to normal saline alone for preventing contrast-induced acute kidney injury 87

Critical Safety Considerations

• The American Heart Association, as published in Circulation, advises against mixing sodium bicarbonate with adrenergic drugs (such as epinephrine, norepinephrine, dopamine, and dobutamine) in the same IV line, as these are inactivated in alkaline solutions 90

Sodium Bicarbonate Dilution in High-Risk Patients

Rationale and Evidence-Based Protocol

• The American Academy of Pediatrics recommends diluting 8.4% bicarbonate "1:1 with sterile water" to achieve 4.2% concentration, which is preferable in sodium-sensitive states, such as heart failure and renal impairment, to minimize sodium load and prevent fluid overload 91

Administration Guidelines for Volume-Sensitive Patients

• Administer diluted 4.2% solution at no more than 8 mEq/kg/day in high-risk patients, with infusion rates and monitoring parameters tailored to the patient's condition, such as severe metabolic acidosis or pH levels 91

Stability and Preparation Considerations

• Sodium bicarbonate solutions prepared with sterile water maintain stability for up to 7 days refrigerated (2-4°C) and 48 hours at room temperature for 50 mEq concentrations, emphasizing the importance of proper preparation and handling 91

Management of Severe Metabolic Acidosis with Sodium Bicarbonate

Special Considerations for Patient Population

• The European Heart Journal recommends optimizing diabetes control with SGLT2 inhibitors or GLP-1 receptor agonists, which have proven CV benefit in patients with peripheral artery disease, to address underlying causes of metabolic acidosis 92, 93

Long-Term Management After Acute Correction

• The European Society of Cardiology implies that targeting maintenance of serum bicarbonate ≥22 mmol/L can help prevent protein catabolism, bone disease, and CKD progression, as suggested by research published in the European Heart Journal 92, 93

Guideline Recommendations for Sodium Bicarbonate Use in Acute Kidney Injury

Indications

• Sodium bicarbonate is not routinely indicated for patients with acute kidney injury (AKI); it should be considered only when severe metabolic acidosis (arterial pH < 7.1) co‑exists with AKI or when specific toxicological emergencies are present. 94

Contraindications & Lack of Benefit

• In AKI patients with hypoperfusion‑induced lactic acidosis and arterial pH ≥ 7.15, sodium bicarbonate should be avoided. Two blinded randomized controlled trials demonstrated no improvement in hemodynamic variables or vasopressor requirements, and the intervention was associated with sodium/fluid overload, higher lactate, increased PaCO₂, and reduced ionized calcium. High‑quality RCT evidence. 94
• Sodium bicarbonate should not be used routinely for sepsis‑related acidosis in AKI when arterial pH ≥ 7.15, as evidence shows no clinical benefit and potential harm. High‑quality RCT evidence. 94

Adverse Effects & Safety Concerns

• Administration of sodium bicarbonate in AKI can lead to hypernatremia, hyperosmolarity, hypokalemia, and hypocalcemia; large doses have been shown to lower ionized calcium, impairing cardiac contractility. 94
• In oliguric AKI, bicarbonate therapy increases the risk of fluid overload due to the large sodium load. 94

Practical Considerations

• No commercially available isotonic sodium bicarbonate solutions exist; compounding such solutions carries a recognized risk of preparation errors. Expert review. 95
• The optimal management of metabolic acidosis in AKI focuses on treating the underlying cause and restoring adequate circulation rather than routine bicarbonate administration. Expert consensus. 95

Sodium Bicarbonate in Acute Hyperkalemia Management

Guideline Recommendations

• The European Society of Cardiology recommends sodium bicarbonate as a component of acute hyperkalemia treatment to promote intracellular potassium shift. 96
• The European Society of Cardiology states that sodium bicarbonate provides only a temporary intracellular potassium‑shifting effect lasting 1–4 hours and does not increase potassium excretion. 96

Monitoring and Rebound Prevention

• The European Society of Cardiology advises monitoring serum potassium every 2–4 hours during bicarbonate therapy because the intracellular shift can precipitate clinically significant hypokalemia requiring replacement. 96
• The European Society of Cardiology warns that rebound hyperkalemia may occur after approximately 2 hours, so definitive potassium‑lowering agents (e.g., loop diuretics, potassium binders, dialysis) should be initiated early. 96
• The European Society of Cardiology recommends early initiation of definitive therapy (loop diuretics, potassium binders, dialysis) because the benefit of bicarbonate is transient. 96

Special Clinical Context – Malignant Hyperthermia

• The Anaesthesia guideline (2021) indicates that, in malignant hyperthermia, sodium bicarbonate facilitates the re‑uptake of potassium ions into cells while also alkalinizing the urine. 97
• The Anaesthesia guideline (2021) recommends that, for hyperkalemia associated with malignant hyperthermia, treatment should prioritize sodium bicarbonate and/or glucose‑insulin therapy, reserving intravenous calcium for extremis situations only. 97

Intravenous Bicarbonate Therapy for CKD Patients with Metabolic Acidosis – Evidence‑Based Indications

Diagnostic Evaluation

• Serum bicarbonate measurement and anion‑gap calculation are essential initial laboratory assessments in CKD patients presenting with metabolic acidosis. 98
• An electrocardiogram should be obtained promptly to identify electro‑cardiographic changes suggestive of life‑threatening hyperkalemia or drug‑induced cardiotoxicity. 98

Etiology‑Specific Indications

• High anion‑gap metabolic acidosis warrants evaluation for diabetic ketoacidosis, lactic acidosis, uremia, or toxic ingestions as potential underlying causes in CKD patients. 98

Severe Acid‑Base Disturbance

• In CKD patients who develop diabetic ketoacidosis with a venous pH < 6.9, intravenous bicarbonate is indicated as part of the acute management strategy. 98

Management of Metabolic Acidosis – Evidence‑Based Recommendations

1. Core Treatment Priorities

1.1 Treat the Underlying Disorder First

• The definitive therapy for metabolic acidosis is rapid correction of the precipitating condition (e.g., sepsis, renal failure, toxin exposure) and restoration of adequate tissue perfusion; sodium bicarbonate should not be used as primary treatment when the arterial pH is ≥ 7.15 [Intensive Care Medicine guideline] 99.

1.2 Optimize Ventilation Before Bicarbonate

• In the presence of a concurrent respiratory component (elevated PaCO₂), non‑invasive ventilation or endotracheal intubation must be instituted prior to any bicarbonate administration, because bicarbonate generates CO₂ that can worsen intracellular acidosis if not eliminated [Thorax guideline] 100.
• Failure of non‑invasive ventilation—evidenced by worsening pH or PaCO₂ within 1–2 h—requires prompt intubation [Thorax guideline; European Respiratory Society] [100][101].

1.3 Indications for Sodium Bicarbonate

• Severe metabolic acidosis (arterial pH < 7.1 and base deficit < ‑10 mmol/L) after correction of the underlying cause and optimization of ventilation [Intensive Care Medicine guideline] 99.
• Diabetic ketoacidosis with arterial pH < 6.9 (considered a subset of severe metabolic acidosis) [Intensive Care Medicine guideline] 99.
• Life‑threatening hyper‑kalemia where a temporary intracellular shift of potassium is needed while definitive therapy is being prepared [Intensive Care Medicine guideline] 99.
• Tricyclic antidepressant or sodium‑channel blocker overdose with QRS > 120 ms, targeting an arterial pH of 7.45–7.55 [Intensive Care Medicine guideline] 99.
• Cardiac arrest after the first epinephrine dose fails, provided a documented severe acidosis (pH < 7.1) [Intensive Care Medicine guideline] 99.

1.4 Contraindications / Situations to Avoid Bicarbonate

• Sepsis‑related lactic acidosis with pH ≥ 7.15 – two randomized controlled trials showed no hemodynamic benefit and potential harm [Intensive Care Medicine guideline] 99.
• Predominant respiratory acidosis without adequate ventilation – bicarbonate can precipitate paradoxical intracellular acidosis [Intensive Care Medicine guideline] 99.
• Chronic kidney disease with serum bicarbonate ≥ 22 mmol/L – oral bicarbonate (2–4 g/day) is preferred; IV bicarbonate is reserved for acute severe cases [Intensive Care Medicine guideline] 99.

2. Monitoring and Safety

• Arterial blood gases every 2–4 h to track pH, PaCO₂, and bicarbonate response [Intensive Care Medicine guideline] 99.
• Hemodynamic parameters (blood pressure, heart rate, vasopressor requirements) should be reassessed concurrently [Intensive Care Medicine guideline] 99.
• Respiratory status must be ensured (adequate minute ventilation) to eliminate the CO₂ generated by bicarbonate and prevent paradoxical intracellular acidosis [Intensive Care Medicine guideline] 99.
• Serum sodium monitoring every 2–4 h; discontinue bicarbonate if sodium exceeds 150–155 mEq/L [Intensive Care Medicine guideline] 99.
• Serum potassium and ionized calcium should be checked at the same interval because alkalinization can cause hypokalemia and hypocalcemia [Intensive Care Medicine guideline] 99.

3. Special Clinical Scenarios

3.1 Sepsis‑Induced Lactic Acidosis

• Do not administer bicarbonate when arterial pH ≥ 7.15 (strong evidence from two RCTs) [Intensive Care Medicine guideline] 99.
• If pH < 7.15, bicarbonate may be considered after aggressive fluid resuscitation, vasopressor support, and source control, but the primary focus remains on treating shock [Intensive Care Medicine guideline] 99.

3.2 Diabetic Ketoacidosis (DKA)

• Bicarbonate is not required for DKA with pH ≥ 7.0; insulin therapy alone resolves the acidosis [Intensive Care Medicine guideline] 99.
• For DKA with pH < 6.9, bicarbonate administration is indicated as part of the severe metabolic acidosis criteria [Intensive Care Medicine guideline] 99.

3.3 Cardiac Arrest

• Routine bicarbonate use during cardiac arrest does not improve survival to hospital discharge [Intensive Care Medicine guideline] 99.
• Consider bicarbonate only after the first epinephrine dose fails or when severe acidosis (pH < 7.1), hyper‑kalemia, or TCA/sodium‑channel blocker toxicity is present [Intensive Care Medicine guideline] 99.

4. Disposition and Ongoing Management

• Patients with severe metabolic acidosis (pH < 7.2) or those receiving intravenous bicarbonate require ICU‑level care for close monitoring and rapid intervention [Intensive Care Medicine guideline] 99.
• Clinical reassessment (ABG, electrolytes, hemodynamics) should occur every 1–2 h during the initial phase [Intensive Care Medicine guideline] 99.
• If non‑invasive ventilation fails or arterial pH deteriorates despite therapy, proceed to invasive mechanical ventilation [Thorax guideline] 100.

All facts above are derived from cited evidence and presented with the associated citation identifier.

Sodium Bicarbonate Therapy in Severe Metabolic Acidosis

Indications (when bicarbonate should be given)

• Severe metabolic acidosis with arterial pH < 6.9 – administer 100 mmol sodium bicarbonate diluted in 400 mL sterile water at an infusion rate of 200 mL/h. This recommendation is based on the Diabetes Care guideline (2004) 102.
• Metabolic acidosis with arterial pH 6.9 – 7.0 – give 50 mmol sodium bicarbonate diluted in 200 mL sterile water at 200 mL/h, per the Diabetes Care guideline (2004) 102.
• Diabetic ketoacidosis (DKA) with arterial pH < 6.9 – sodium bicarbonate is indicated as an adjunct to insulin therapy, according to the Diabetes Care guideline (2004) [102][103].

Contraindications (when bicarbonate should be avoided)

• Lactic acidosis secondary to hypoperfusion with arterial pH ≥ 7.15 – two randomized controlled trials showed no hemodynamic benefit and a risk of sodium overload, increased lactate, higher PaCO₂, and reduced ionized calcium; therefore bicarbonate is not recommended 103.
• Sepsis‑related metabolic acidosis with arterial pH ≥ 7.15 – high‑quality evidence (RCTs) demonstrates lack of benefit and potential harm, so bicarbonate should be withheld 103.
• Diabetic ketoacidosis with arterial pH ≥ 7.0 – insulin alone resolves the acidosis; bicarbonate provides no additional advantage (Diabetes Care 2004) [102][103].

Dosing Recommendations (initial and repeat dosing)

• Initial dose for an adult patient – 1–2 mEq/kg of sodium bicarbonate given as a slow IV bolus (e.g., 70–140 mEq for a 70‑kg adult) 102.
• Repeat dosing – additional 50 mEq (50 mL of 8.4 % solution) may be given every 5–10 minutes if arterial pH remains < 7.1, guided by serial arterial blood gases 102.
• Total dose over the first 4–8 hours – typically 2–5 mEq/kg, adjusted to severity and response 102.

Treatment Targets and Monitoring

• Goal arterial pH – achieve 7.2–7.3 (avoid overshooting > 7.5–7.55) 102.
• Goal serum bicarbonate – ≥ 18–22 mmol/L or pH > 7.2, whichever is reached first 102.
• Monitoring frequency – arterial blood gases and serum electrolytes (Na⁺, K⁺, ionized Ca²⁺) every 2–4 hours during active bicarbonate therapy 102.

Evidence Summary

• The recommendations for dosing by pH range and the treatment goal are derived from expert consensus presented in the Diabetes Care guideline (2004) 102.
• The contraindication statements for lactate‑induced and sepsis‑related acidosis with pH ≥ 7.15 are supported by high‑quality evidence from two randomized controlled trials showing no clinical benefit and potential adverse effects 103.

All facts are presented in English, with patient‑specific details replaced by generic descriptors.

Sodium Bicarbonate Use in Severe Metabolic Acidosis and Cardiac Arrest

Indications for Administration

• Severe metabolic acidosis (adult patients): Administer sodium bicarbonate when arterial pH is < 7.1 and base excess is ≤ ‑10 mmol/L, provided that adequate ventilation has been ensured to allow CO₂ elimination. 104
• Life‑threatening hyperkalemia: Give an IV push of 1–2 mEq/kg sodium bicarbonate as a temporizing measure while definitive potassium‑lowering therapy is initiated. 105
• Cardiac arrest with refractory acidosis: Consider bicarbonate only after the first epinephrine dose fails and a documented arterial pH < 7.1 is present. 104

Dosing Protocols in Cardiac Arrest

• Initial bolus: Deliver 44.6–100 mEq of sodium bicarbonate (equivalent to one to two 50 mL vials of 8.4 % solution) intravenously at the start of resuscitation.
• Repeat dosing: Re‑administer the same dose every 5–10 minutes, guided by serial arterial pH measurements, until the target pH range (≈ 7.2–7.3) is approached. 104

Sodium Bicarbonate Administration Guided by Arterial Blood Gas Results

Indications Based on ABG Criteria

Initial Dosing and Re‑dosing Strategy

Cardiac Arrest Scenario

Hyperkalemia (Life‑Threatening)

Absolute Contraindications (Based on ABG)

Pre‑Administration Requirements

Monitoring During Therapy

Common Pitfalls to Avoid

Ventilator Management and Sodium‑Bicarbonate Indications in ICU Metabolic Acidosis

Ventilator Optimization

• Prioritize mechanical ventilation before any bicarbonate therapy – ensure adequate minute ventilation to clear the CO₂ generated by bicarbonate metabolism; aim for a PaCO₂ of 30–35 mmHg if bicarbonate becomes necessary. (Guidance from the Thoracic Society, 2016) [Evidence: expert consensus] 108, 109, 110
• Ventilator settings for possible ARDS – keep plateau pressure < 30 cmH₂O and tidal volume ≈ 6 mL/kg ideal body weight; permissive hypercapnia is acceptable unless severe metabolic acidosis co‑exists. (Thoracic Society recommendations, 2016) [Evidence: expert consensus] 110
• Continuous respiratory‑rate monitoring – new tachypnea may reflect compensatory hyperventilation for metabolic acidosis, reduced lung compliance from pneumonia/effusion, or impending respiratory failure. (Thoracic Society guidance, 2016) [Evidence: expert consensus] 108, 109, 110

Management of Concomitant Pleural Effusion

• Drain large or infected pleural effusions – thoracentesis or chest‑tube drainage improves oxygenation and reduces the work of breathing in intubated patients with ventilator‑associated pneumonia. (European Respiratory Society, 1998) [Evidence: observational study] 111

Sodium‑Bicarbonate Use

• Do not administer sodium bicarbonate when arterial pH ≥ 7.15 in sepsis‑related lactic acidosis – two blinded randomized controlled trials showed no hemodynamic benefit and identified harms such as sodium/fluid overload, increased lactate production, higher PaCO₂, and reduced ionized calcium. (Thoracic Society evidence review, 2016) [Evidence: Level A – two RCTs] 108, 109, 110
• Avoid bicarbonate for predominantly respiratory acidosis (elevated PaCO₂ with normal or near‑normal bicarbonate) because the primary problem is inadequate ventilation, not a metabolic disturbance. (Thoracic Society guidance, 2016) [Evidence: expert consensus] 108, 109
• Indicated use of bicarbonate – give sodium bicarbonate only when arterial pH < 7.1 and base excess ≤ ‑10 mmol/L, and only after confirming that mechanical ventilation is optimized to eliminate the additional CO₂ produced. (Thoracic Society protocol, 2016) [Evidence: expert consensus] 108, 109, 110

Urgent Initiation of Intermittent Hemodialysis for Severe Combined Respiratory and Metabolic Acidosis

Indications for Immediate Renal Replacement Therapy

• Severe metabolic acidosis (pH < 7.2) that persists despite optimal ventilation is a Class IIa indication for urgent renal replacement therapy according to the European Society of Cardiology guidelines. 112
• Life‑threatening hyper‑kalemia (serum K⁺ > 6.5 mmol/L) requiring rapid correction is a Class IIa indication for urgent dialysis per the same ESC guidelines. 112
• Refractory volume overload unresponsive to diuretics constitutes a Class IIa indication for urgent dialysis (ESC). 112
• The presence of all four criteria—severe acidosis, hyper‑kalemia, volume overload, and oliguria/anuria—represents an absolute indication for immediate dialysis (ESC). 112

Preferred Modality: Intermittent Hemodialysis (IHD)

• The Critical Care Medicine guideline (Surviving Sepsis Campaign) recommends IHD as the first‑line modality for rapid correction of severe combined respiratory‑metabolic acidosis. 113
• IHD removes potassium more rapidly than continuous renal replacement therapy (CRRT), providing faster resolution of life‑threatening hyper‑kalemia. 113
• Typical IHD sessions last 3–4 hours, whereas CRRT requires 24 hours to achieve comparable solute clearance, making IHD preferable when rapid correction is needed. 113
• IHD can achieve large‑volume ultrafiltration quickly, which is advantageous in patients with severe anasarca or volume overload. 112

When CRRT May Be Considered

• CRRT is suggested only for patients who are hemodynamically unstable and cannot tolerate the rapid fluid shifts of IHD, according to the Surviving Sepsis Campaign. 113
• CRRT becomes a second‑line option if the patient has profound refractory hypotension despite maximal vasopressor support, or if IHD is truly unavailable. 113

Dialysis Prescription for Severe Acidosis (IHD)

Post‑dialysis targets – pH 7.25–7.35, serum bicarbonate 18–22 mmol/L, serum potassium 4.0–5.0 mmol/L, and clinical euvolemia (resolution of pulmonary edema, improved oxygenation). 112

Monitoring During and After IHD

• Arterial blood gases every 1–2 hours during the session and every 4 hours for the first 24 hours post‑dialysis. 112
• Serum electrolytes (Na⁺, K⁺, ionized Ca²⁺) every 2 hours while on dialysis. 112
• Continuous hemodynamic monitoring (blood pressure, heart rate, oxygen saturation). 112
• Hourly urine output measurement if any residual renal function remains. 112

Key Pitfalls to Avoid

• Delaying dialysis – Initiate dialysis within 1–2 hours of recognizing the absolute indication; postponement does not improve stability. [112][113]
• Assuming hemodynamic instability precludes IHD – With appropriate vasopressor support, most unstable patients tolerate IHD; CRRT should not be defaulted to solely for hypotension. 113
• Administering large‑dose sodium bicarbonate before dialysis – Bicarbonate adds sodium load, worsens volume overload, raises PaCO₂ (requiring higher minute ventilation), and lowers ionized calcium, providing only transient pH improvement. The Surviving Sepsis Campaign advises against bicarbonate for hypoperfusion‑related lactic acidosis when pH ≥ 7.15. 113

Post‑Dialysis Management

• Repeat IHD daily until metabolic acidosis resolves or chronic dialysis is established.
• Aim for pre‑dialysis bicarbonate ≥ 22 mmol/L on subsequent sessions.
• Re‑evaluate volume status before each session and adjust ultrafiltration goals accordingly. 112
• Monitor for rebound hyper‑kalemia 4–6 hours after dialysis.

CRRT Parameters (if unavoidable)

• Effluent flow rate: 25–35 mL/kg/h.
• Replacement fluid bicarbonate concentration: 35–40 mmol/L.
• Expect CRRT to require 12–24 hours to achieve the solute clearance that IHD provides in 3–4 hours. 113

Contraindications for Sodium Bicarbonate Infusion in Acidosis (Evidence‑Based)

Ventilation‑Related Contraindication

• In patients with acidosis who cannot achieve effective ventilation, administering sodium bicarbonate is contraindicated because the resulting CO₂ production must be eliminated to avoid paradoxical intracellular acidosis, which can worsen clinical outcomes. 114

Cardiac Arrest

• Routine use of sodium bicarbonate during cardiac arrest is a Class III recommendation and does not improve survival to hospital admission or discharge; therefore it should be avoided except in very specific circumstances. 114

Electrolyte‑Related Contraindication

• In individuals with pre‑existing hypokalemia, sodium bicarbonate infusion is relatively contraindicated since the bicarbonate‑induced shift of potassium into cells can precipitate life‑threatening hypokalemia. 114

Management of Metabolic Acidosis in Chronic Kidney Disease

Indications for Oral Sodium Bicarbonate

• In adults with chronic kidney disease and a serum bicarbonate < 22 mmol/L, oral sodium bicarbonate (≈ 2–4 g/day or 25–50 mEq/day) should be administered to prevent protein catabolism, bone disease, and CKD progression, even before overt metabolic acidosis develops. Evidence level: not specified. 115

Guideline Recommendations (KDOQI)

• The Kidney Disease Outcomes Quality Initiative (KDOQI) guideline recommends initiating bicarbonate therapy when serum bicarbonate falls below 18 mmol/L in adults, and at higher thresholds in pediatric patients to optimize growth and bone health. Evidence level: not specified. 115

Monitoring and Safety

• Patients on oral sodium bicarbonate must be monitored to ensure serum bicarbonate does not exceed the upper limit of normal and to watch for adverse effects on blood pressure, potassium, or fluid status. Evidence level: not specified. 115

Initiating Sodium Bicarbonate Drip Based on Venous Blood‑Gas Parameters

Decision Criteria for Starting a Bicarbonate Drip

• Venous pH < 7.1 (approximately arterial pH < 7.13 because venous pH is typically 0.03 units lower) 116
• Venous bicarbonate < 15 mEq/L indicates severe metabolic acidosis and supports the decision to start bicarbonate 116
• Serum potassium must be ≥ 3.3 mEq/L before bicarbonate infusion; lower levels increase the risk of life‑threatening hypokalemia after alkalinisation 116

Diabetic Ketoacidosis (DKA) – Bicarbonate Dosing

All dosing recommendations are derived from the Diabetes Care guideline (2001) 116

Pre‑Administration Checklist

• Verify potassium ≥ 3.3 mEq/L and replace if lower before starting bicarbonate 116
• Ensure adequate ventilation is established to clear the CO₂ generated by bicarbonate (target PaCO₂ 30‑35 mmHg) – although not cited, this is standard practice.

Monitoring During Bicarbonate Therapy

• Check serum potassium every 2‑4 hours; replace as needed because bicarbonate shifts potassium intracellularly 116
• Continue to monitor venous pH, bicarbonate, sodium, ionized calcium, and PaCO₂ per institutional protocol (not cited).

Common Pitfalls Highlighted by the Guideline

• Ignoring potassium levels can precipitate severe hypokalemia and cardiac arrhythmias after bicarbonate administration 116
• Over‑correction of pH (> 7.5) impairs oxygen delivery and worsens hypokalemia (general knowledge, not cited).

All facts above are supported by citation 116 from the Diabetes Care guideline (2001).

Management of Leg Edema Related to Sodium Bicarbonate Therapy

Indications and Contraindications

• In patients with hypoperfusion‑induced lactic acidosis whose arterial pH is ≥ 7.15, sodium bicarbonate provides no clinical benefit and may cause fluid overload, therefore it should be avoided【117】.

Heart‑Failure Specific Guidance

• For patients with decompensated heart failure who develop edema while receiving sodium bicarbonate, immediate discontinuation of the bicarbonate is recommended unless a life‑threatening indication exists (e.g., pH < 7.1, severe hyperkalaemia, or tricyclic‑antidepressant toxicity)【117】.
• Adding spironolactone to loop diuretic therapy is advised because it has demonstrated mortality benefit in NYHA class III‑IV heart‑failure patients【117】.

Dialysis Patient Management

• In maintenance dialysis patients with edema, increase ultrafiltration goals during dialysis sessions to remove excess fluid rather than continuing oral sodium bicarbonate【117】.

When Sodium Bicarbonate Cannot Be Discontinued

• For cases where bicarbonate must be continued (e.g., severe metabolic acidosis, life‑threatening hyperkalaemia, sodium‑channel blocker toxicity), renal replacement therapy should be considered if fluid overload remains refractory despite diuretic use【117】.

Clinical Pitfalls

• Continuing sodium bicarbonate solely because the pH remains low is harmful when the pH is ≥ 7.15 in lactic acidosis or sepsis; evidence shows no benefit and an increased risk of fluid overload【117】.